← Fulgent Genetics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $18.3m |
$18.7m
+2.48%
|
$21.4m
+13.99%
|
$32.5m
+52.35%
|
$421.7m
+1196.46%
|
$992.6m
+135.37%
|
$619.0m
-37.64%
|
$289.2m
-53.27%
|
$283.5m
-1.99%
|
$322.7m
+13.83%
|
$323.9m
+0.39%
|
|
| Cost of Revenue | $6.7m |
$8.6m
+27.21%
|
$0
-100.00%
|
$0 | $89.8m |
$215.5m
+140.00%
|
$252.1m
+16.95%
|
$184.8m
-26.70%
|
$176.3m
-4.60%
|
$191.8m
+8.82%
|
$208.7m
+8.80%
|
|
| Gross Profit | $11.6m |
$10.2m
-11.90%
|
$10.7m
+4.67%
|
$18.4m
+72.90%
|
$331.9m
+1701.78%
|
$777.1m
+134.12%
|
$366.9m
-52.78%
|
$104.5m
-71.53%
|
$107.2m
+2.64%
|
$130.9m
+22.07%
|
$115.3m
-11.93%
|
|
| Research and Development Expense | $3.6m | $4.2m | $5.5m | $6.5m | $11.6m | $24.2m | $28.9m | $41.4m | $48.8m | $53.9m | $56.8m | |
| Selling and Marketing Expense | $2.5m | $4.2m | $4.7m | $5.9m | $15.0m | $24.4m | $38.9m | $41.5m | $36.2m | $43.4m | $169.9m | |
| General and Administrative Expense | $4.6m | $5.2m | $5.5m | $6.4m | $15.2m | $50.7m | $111.1m | $89.0m | $88.1m | $116.7m | $119.9m | |
| Amortization of Intangible Assets | — | — | — | — | — | $1.7m | $6.5m | $7.8m | $8.0m | $8.0m | — | |
| Operating Lease, Lease Income | — | — | — | — | $145k | $420k | $281k | $164k | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | $3.0m | $0 | $0 | — | — | |
| Operating Expenses | $10.6m | $13.7m | $15.7m | $18.8m | $41.7m | $101.1m | $188.4m | $300.0m | $181.1m | $222.0m | $235.4m | |
| Operating Income (Loss) | $918k |
($3.5m)
-479.30%
|
($5.1m)
-45.61%
|
($428k)
+91.56%
|
$290.2m
+67893.93%
|
$676.0m
+132.96%
|
$178.5m
-73.59%
|
($195.5m)
-209.52%
|
($73.9m)
+62.20%
|
($91.1m)
-23.24%
|
($120.1m)
-31.85%
|
|
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | — | — | — | — | — | — | — | — | ($994k) | $62k | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | $561k | $153k | — | |
| Interest Expense (non-operating) | — | — | — | — | $20k | $117k | $346k | $488k | ($170k) | $75k | $120k | |
| Income (Loss) from Equity Method Investments | — | ($524k) | ($935k) | ($777k) | ($488k) | — | — | — | — | — | — | |
| Interest and Other Income | — | — | — | $837k | $1.5m | $1.3m | $5.5m | $21.4m | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $4.5m | — | — | $679k | $291.7m | $681.4m | $189.4m | ($147.5m) | ($46.8m) | ($61.8m) | ($92.5m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($4.5m) | — | — | $409k | $291.7m | $677.3m | $184.0m | ($174.1m) | ($52.0m) | ($70.0m) | ($92.5m) | |
| Current Income Tax Expense (Benefit) | $674k | ($679k) | $0 | $43k | $74.3m | $183.0m | $50.4m | ($10.3m) | ($4.4m) | ($7.3m) | ($7.0m) | |
| Income Tax Expense (Benefit) | $920k | ($1.0m) | $36k | $43k | $72.5m | $174.8m | $42.1m | $1.2m | ($8.1m) | ($8.4m) | ($7.0m) | |
| Net Income (Loss) Attributable to Parent | ($5.3m) |
($2.5m)
+53.06%
|
($5.6m)
-123.39%
|
($411k)
+92.67%
|
$214.3m
+52243.55%
|
$507.4m
+136.74%
|
$143.4m
-71.74%
|
($167.8m)
-217.03%
|
($42.7m)
+74.55%
|
($60.5m)
-41.69%
|
($84.4m)
-39.44%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | ($1.1m) | ($1.5m) | ($7.4m) | ($1.1m) | ($1.1m) | ($84.4m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | ($0) | ($0) | $9 | $17 | $5 | ($6) | ($1) | ($2) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | ($0) | ($0) | $9 | $16 | $5 | ($6) | ($1) | ($2) | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 18.0m | 18.7m | 22.7m | 29.4m | 30.1m | 29.8m | 30.2m | 30.8m | 30.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 18.0m | 18.7m | 24.1m | 31.0m | 31.0m | 29.8m | 30.2m | 30.8m | 30.2m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | $120.2m | $0 | $0 | $2.2m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($5.4m) | ($2.5m) | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $41k | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $41k | $0 | — | — | — | — | — | — | — | — | — |